Navigation Links
Valium hits 40 years old, anxiety-free

Valium, the drug that revolutionized the treatment of anxiety and became a cultural icon, is 40 years old this year.
The drug owes its success to the stubborn streak of chemist Leo Sternbach, who refused to quit after his boss at Hoffmann-La Roche ended a project to develop a tranquilizer to compete with a rival company's drug. Sternbach tested one last version and in just a day, he got the results: The compound made animals relaxed and limp.//

Sternbach had made the discovery that eventually led to Valium. It was approved for use in 1963 and became the country's most prescribed drug from 1969 to 1982. Valium also was referred to as a "doll" -- one of the pills popped by female characters in novelist Jacqueline Susann's racy 1966 best-seller "Valley of the Dolls." Most of the prescriptions were written by family doctors rather than psychiatrists, and the majority of users were women.

With Valium, Sternbach gave the company its first blockbuster. Sternbach had created an entire new class of tranquilizers named benzodiazepines, which were safer and more effective than previous treatments such as barbiturates, opiates, alcohol and herbs. Unlike earlier drugs, Valium did not slow breathing, so patients couldn't use it to commit suicide. But it was overused, Sternbach said; some patients became addicted, so a doctor's visit was required for refills.

Still, benzodiazepines remain the most prescribed anxiety drugs, partly because they start working as fast as one hour, slowing brain activity. They also are used for treating panic and phobia disorders and insomnia, calming patients before surgery and relaxing muscles. Sternbach officially retired in 1973, but worked most days until recently. He mentored young scientists, corresponded and consulted with others, and worked on his biography, due out this fall under the title, "Good Chemistry: The Life and Times of Valium Inventor Leo Sternbach." Sternbach's credits include 241 patents, 122 pu blications, honorary degrees and other awards. His other breakthroughs include the sleeping pills Dalmane and Mogadon, Klonopin for epileptic seizures and Arfonad, for limiting bleeding during brain surgery.

"He's an inventor's inventor," "Within every company, there is a person or two whose legacy becomes the hallmark of what the company is about, and for Roche, it is Dr. Sternbach."
'"/>




Related medicine news :

1. Test tube babies, 25 years later
2. Diabetes cases could double in developing countries in next 30 years
3. Larynx transplant restores patients voice after 20 years
4. New Blood Thinner Pill - First Potential Alternative to Warfarin in 50 years
5. Microbicides could serve to materialise women empowerment in the years to come
6. Diagnosis of Alzheimers years before clinical signs emerge
7. Induced abortion results in years of trauma.
8. 10 Million Indian Females Aborted In 20 years
9. Loss and damage to the brain cells possible with lead exposure in years ahead
10. Womb transplantation- to be successful in 2 years’ tim
11. Babies under two years of age to be administered Meningitis vaccination
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/18/2017)... ... February 17, 2017 , ... CONTACT:, Glenn Vallecillos, MD, FACS, ... surgeon Dr. Glenn Vallecillos experiments SculpSure, the hot, new, aesthetic, non-surgical ... has been centered around that idea that to achieve ones desired results a ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... pace. Enovate Medical has introduced an innovative workstation designed to reduce nursing fatigue ... the Encore Mobile EHR Workstation offers a lightweight, highly mobile, multi-functional alternative to ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... Dr. Carol Francis' goals for each and every seminar, session and ... Francis will demonstrate five different brainwave tools which help energize creativity, focus mental ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... services, announced today that Karen Pilley has been promoted to Chief Executive Officer. ... today’s shifting healthcare paradigm – a shift that demands the transition from pay-for-service ...
(Date:2/17/2017)... ... February 17, 2017 , ... Top neuroendocrine cancer doctors, nurses and ... Summit from February 21 - 23 in Beaver Creek, CO. It was announced today ... Summit’s second year in Beaver Creek, hosting over 60 faculty members and addressing unmet ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... -- Absorption Systems, a global leader in nonclinical testing ... announce that its Chief Operating Officer, Sid Bhoopathy ... the 2017 Executive Management Award. The award is sponsored ... for their creative management vision, leadership philosophy, innovative strategy ... is on March 8, 2017 at the Ballroom at ...
(Date:2/16/2017)... N.J. , Feb. 16, 2017 Quest ... provider of diagnostic information services, today announced that it ... Companies" for 2017 by Fortune. The ... six companies in the "Health Care: Pharmacy and Other ... only diagnostic information services company to attain the designation. ...
(Date:2/16/2017)... , Feb. 16, 2017 The global ... USD 7.88 billion by 2021 from USD 5.49 billion ... On the basis of type, the preparative and ... preparative chromatography. In 2016, the process chromatography segment is ... global preparative and process chromatography. Growth in this segment ...
Breaking Medicine Technology: